Literature DB >> 30363310

Correlation between transepidermal water loss (TEWL) and severity of clinical symptoms in cats with atopic dermatitis.

Marcin P Szczepanik1, Piotr M Wilkołek1, Łukasz R Adamek1, Grzegorz Kalisz1, Marcin Gołyński1, Wiesław Sitkowski1, Iwona Taszkun1.   

Abstract

The aim of this study was to demonstrate whether there is a correlation between transepidermal water loss (TEWL) and the severity of skin lesions in cats with feline atopic dermatitis (AD). The severity of symptoms was determined by using 2 scoring systems for clinically assessing the skin lesions in cats: Scoring Feline Allergic Dermatitis (SCORFAD) and Feline Extent and Severity Index (FeDESI). Such a correlation between TEWL and systems for clinically evaluating symptoms has already been shown in humans and dogs. Measurements were taken in 18 European Shorthair cats: 11 females and 7 males. Scores were calculated using SCORFAD and FeDESI and TEWL was measured in 7 areas of the body. Correlations were calculated between SCORFAD and TEWL and between FeDESI and TEWL for each body region and the average TEWL was also calculated with each system. Positive correlations were found between SCORFAD and TEWL in 3 of the examined areas: thorax (r = 0.44, P = 0.02); axilla (r = 0.39, P = 0.04); and forelimb (r = 0.55, P = 0.02). A correlation was also found between the average TEWL and SCORFAD (r = 0.41, P = 0.03). In the case of FeDESI, a correlation was found in the forelimb (r = 0.53, P = 0.02), but no correlation was found between FeDESI and the average TEWL. The results obtained showed that TEWL can be used as an additional tool in clinically assessing atopic dermatitis in cats, although it seems to be less useful in cats than in humans.

Entities:  

Mesh:

Year:  2018        PMID: 30363310      PMCID: PMC6168015     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  26 in total

1.  Assessment of atopic eczema: clinical scoring and noninvasive measurements.

Authors:  E A Holm; H C Wulf; L Thomassen; G B E Jemec
Journal:  Br J Dermatol       Date:  2007-08-02       Impact factor: 9.302

2.  The influence of non-specific anti-pruritus treatment with cyclosporine A on transepidermal water loss (TEWL) in natural atopic dermatitis in dogs.

Authors:  M Zając; M Szczepanik; P Wilkołek; Ł Adamek; Z Pomorski
Journal:  Pol J Vet Sci       Date:  2015       Impact factor: 0.821

3.  The examination of biophysical skin parameters (transepidermal water loss, skin hydration and pH value) in different body regions in Polish ponies.

Authors:  M P Szczepanik; P M Wilkolek; M Pluta; L R Adamek; M Golyński; Z J H Pomorski; W Sitkowski
Journal:  Pol J Vet Sci       Date:  2013       Impact factor: 0.821

4.  Assessment of a correlation between Canine Atopic Dermatitis Extent and Severity Index (CADESI-03) and selected biophysical skin measures (skin hydration, pH, and erythema intensity) in dogs with naturally occurring atopic dermatitis.

Authors:  Marcin Zając; Marcin P Szczepanik; Piotr M Wilkołek; Łukasz R Adamek; Zbigniew J H Pomorski; Wiesław Sitkowski; Marcin Gołyński
Journal:  Can J Vet Res       Date:  2015-04       Impact factor: 1.310

5.  Responsiveness and validity of the SCORFAD, an extent and severity scale for feline hypersensitivity dermatitis.

Authors:  Jean Steffan; Thierry Olivry; Sophie L Forster; Wolfgang Seewald
Journal:  Vet Dermatol       Date:  2012-07-24       Impact factor: 1.589

6.  Effects of age and allergen exposure on transepidermal water loss in a house dust mite-sensitized beagle model of atopic dermatitis.

Authors:  Katherine Hightower; Rosanna Marsella; Alison Flynn-Lurie
Journal:  Vet Dermatol       Date:  2010-02       Impact factor: 1.589

7.  Assessment of the relationship between transepidermal water loss (TEWL) and severity of clinical signs (CADESI-03) in atopic dogs.

Authors:  Marcin Zając; Marcin P Szczepanik; Piotr M Wilkołek; Lukasz R Adamek; Zbigniew J H Pomorski; Wiesław Sitkowski; Marcin G Gołyński
Journal:  Vet Dermatol       Date:  2014-08-06       Impact factor: 1.589

8.  Establishment of diagnostic criteria for feline nonflea-induced hypersensitivity dermatitis.

Authors:  Claude Favrot; Jean Steffan; Wolfgang Seewald; Stefan Hobi; Monika Linek; Geneviève Marignac; Thierry Olivry; Luc Beco; Claudia Nett; Jacques Fontaine; Petra Roosje; Kerstin Bergvall; Svetlana Belova; Stefanie Koebrich; Didier Pin; Marcel Kovalik; Sabrina Meury; Sylvia Wilhelm
Journal:  Vet Dermatol       Date:  2011-09-07       Impact factor: 1.589

9.  Transepidermal water loss (TEWL) reflects skin barrier function of dog.

Authors:  Kenichiro Shimada; Toru Yoshihara; Masahiko Yamamoto; Katsuhiko Konno; Yasuyuki Momoi; Koji Nishifuji; Toshiroh Iwasaki
Journal:  J Vet Med Sci       Date:  2008-08       Impact factor: 1.267

10.  Evaluation of the effect of a 0.0584% hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis.

Authors:  Eui-Hwa Nam; Seol-Hee Park; Ji-Young Jung; Seung-Hee Han; Hwa-Young Youn; Jun-Seok Chae; Cheol-Yong Hwang
Journal:  J Vet Sci       Date:  2012-06       Impact factor: 1.672

View more
  3 in total

Review 1.  Recent advances in the anti-aging effects of phytoestrogens on collagen, water content, and oxidative stress.

Authors:  Tao Liu; Nan Li; Yi-Qi Yan; Yan Liu; Ke Xiong; Yang Liu; Qing-Mei Xia; Han Zhang; Zhi-Dong Liu
Journal:  Phytother Res       Date:  2019-11-20       Impact factor: 5.878

2.  Topical N-palmitoyl serinol, a commensal bacterial metabolite, prevents the development of epidermal permeability barrier dysfunction in a murine model of atopic dermatitis-like skin.

Authors:  Si Wen; Li Ye; Dan Liu; Bin Yang; Mao-Qiang Man
Journal:  Can J Vet Res       Date:  2021-07       Impact factor: 1.310

3.  The examination of biophysical parameters of the skin in Polish Konik horses.

Authors:  Agnieszka Cekiera; Jarosław Popiel; Marta Siemieniuch; Zbigniew Jaworski; Malwina Slowikowska; Natalia Siwinska; Agnieszka Zak; Artur Niedzwiedz
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.